BlackRock Institutional Trust’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $29.3M | Sell |
1,755,099
-79,760
| -4% | -$1.33M | ﹤0.01% | 1686 |
|
|
2016
Q3 | $37.8M | Buy |
1,834,859
+1,568
| +0.1% | +$32.3K | 0.01% | 1463 |
|
|
2016
Q2 | $56.1M | Sell |
1,833,291
-32,139
| -2% | -$983K | 0.01% | 1167 |
|
|
2016
Q1 | $69.8M | Buy |
1,865,430
+121,266
| +7% | +$4.54M | 0.01% | 1033 |
|
|
2015
Q4 | $75.3M | Buy |
1,744,164
+70,504
| +4% | +$3.04M | 0.01% | 1000 |
|
|
2015
Q3 | $62.7M | Sell |
1,673,660
-57,307
| -3% | -$2.15M | 0.01% | 1106 |
|
|
2015
Q2 | $58.8M | Sell |
1,730,967
-142,168
| -8% | -$4.83M | 0.01% | 1208 |
|
|
2015
Q1 | $66.3M | Sell |
1,873,135
-38,974
| -2% | -$1.38M | 0.01% | 1156 |
|
|
2014
Q4 | $65.1M | Buy |
1,912,109
+48,254
| +3% | +$1.64M | 0.01% | 1121 |
|
|
2014
Q3 | $71.9M | Sell |
1,863,855
-8,577
| -0.5% | -$331K | 0.01% | 1037 |
|
|
2014
Q2 | $72.9M | Sell |
1,872,432
-14,529
| -0.8% | -$565K | 0.01% | 1071 |
|
|
2014
Q1 | $64.5M | Sell |
1,886,961
-280,729
| -13% | -$9.6M | 0.01% | 1126 |
|
|
2013
Q4 | $45.5M | Buy |
2,167,690
+172,634
| +9% | +$3.62M | 0.01% | 1327 |
|
|
2013
Q3 | $46.9M | Sell |
1,995,056
-95,165
| -5% | -$2.24M | 0.01% | 1244 |
|
|
2013
Q2 | $56.2M | Buy |
+2,090,221
| New | +$56.2M | 0.01% | 1076 |
|